Abraxane Reps Will Number 100: Approval Of Novel Paclitaxel Formulation Expected In Third Quarter

American Pharmaceutical Partners hopes to position metastatic breast cancer drug as superior to Taxol in safety, convenience and effectiveness. Parent company American Bioscience filed the NDA in early March and expects a priority review.